Topics

Medtronic gets FDA nod for Evolut PRO+ TAVR system

07:16 EDT 24 Sep 2019 | Compelo Medical Devices

Medtronic has secured approval from the US Food and Drug Administration (FDA) for its next-generation Evolut PRO+ TAVR system to treat symptomatic severe aortic stenosis patients. The company

The post Medtronic gets FDA nod for Evolut PRO+ TAVR system appeared first on NS Medical Devices.

Original Article: Medtronic gets FDA nod for Evolut PRO+ TAVR system

NEXT ARTICLE

More From BioPortfolio on "Medtronic gets FDA nod for Evolut PRO+ TAVR system"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...